Lung Biopsy Systems Market Size, Share, Growth And Demand Analysis

(MENAFN- America News Hour) Lung Biopsy Systems market report which delivers a detailed overview of the global lung biopsy systems marketin terms of market segmentation by product type, procedure type, end-user, and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, and supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.

Lung Biopsy Systems Market Statistics –

  • USD 3 billion revenue in 2022
  • The market size is projected to record a valuation of over USD 16 billion by 2035
  • The membrane filtration industry is slated to observe 15% growth rate through 2023-2035

Get Free Sample Copy of this Report @ global lung biopsy systems market is projected to grow at a CAGR of ~10% by attaining a remarkable revenue during the forecast period, i.e., 2022 – 2031. A significant requirement for lung biopsy systems owing to the higher prevalence of lung diseases across the globe is anticipated to propel the growth of the market during the forecast period.
World Health Organization (WHO) published a report showing that in 2019, 3.23 million people died due to chronic obstructive pulmonary disease (COPD)[IT1]
Additionally, by procedure type, the global lung biopsy systems market is segmented into transbronchial, thoracoscopic, and open biopsy. Out of these sub-segments, the open biopsy segment is estimated to obtain a notable share in the market during the forecast period. The growth of the segment can be accounted to the requirement for open biopsy by a large number of patients. Open biopsy is usually performed to diagnose the early sign of any sort of disease in the lungs.
For instance, about 0.5 million bronchoscopies are performed annually in the USA.
Bronchoscopy is a procedure that is utilized to diagnose and treat lung diseases by examining air passages.

The research is global in nature and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook, etc. have also been covered and displayed in the research report.

According to recent study by Research Nester, the Lung Biopsy Systems Market size is anticipated to surpass USD 16 Bn by 2035 and is projected to expand at CAGR of over 15% from 2023 to 2035.

Major players include in the global Lung Biopsy Systems Market:

  • Argon Medical Devices, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Fujifilm Corporation
  • Cardinal Health, Inc.
  • DTR Medical Ltd
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Hologic Inc.
  • Medtronic Limited
  • Zimmer Biomet Holdings, Inc.

Get Free Sample Copy of this Report @

Rising Cases of Lung Cancer to Foster the Growth of the Market

In 2020, about 2 million people of the global population were projected to have lung cancer.[IT3]

In lung biopsy, samples of lung tissues are taken or removed with the assistance of specialized biopsy needles to diagnose lung cancer and other types of diseases.
A lung biopsy is generally performed in two methods that are closed and open methods.Therefore, this requirement of lung biopsy is anticipated to propel the growth of the market during the forecast period.

However, the possibility of side effects such as, blood loss and pneumonia is expected to operate as a key restraint to the growth of the global lung biopsy systems market over the forecast period.

Buy a Copy of this Strategic Report to drive your Business Growth

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided the right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel


U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919


America News Hour

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.